Back to Search
Start Over
Supplementary Figure 4 from CA-125 ELIMination Rate Constant K (KELIM) Is a Marker of Chemosensitivity in Patients with Ovarian Cancer: Results from the Phase II CHIVA Trial
- Publication Year :
- 2023
- Publisher :
- American Association for Cancer Research (AACR), 2023.
-
Abstract
- Receiver Operating Characteristics curve regarding Complete interval debulking surgery (Yes vs No) according to KELIM. Selection of the best predictive KELIM cut-off using Youden index.
Details
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....0a694834338a82bed560ee0412a3e531
- Full Text :
- https://doi.org/10.1158/1078-0432.22477443